As manager of Pew's drug safety project, Cosel works on federal initiatives to ensure the safety and oversight of the U.S. pharmaceutical supply chain. Prior to joining Pew, Cosel worked on issues of pharmaceutical safety and appropriate prescribing for national advocacy Organization Community Catalyst, and in grassroots development and capacity-building with the Fund for Public Interest Research in Cambridge, Massachusetts.
Cosel received her M.Sc. in human rights from the London School of Economics and a BA from Yale University.
Recent WorkView All
When compounded drugs are created in large volumes and shipped across the country, as was the case with injections linked to the national meningitis outbreak, producers should meet some of the same quality assurance requirements as drug manufacturers. Read More
Pew and other health care organizations released a report exploring measures that should be considered to address the ongoing issue of drug shortages in the United States, which impacts lifesaving medicines including antibiotics, chemotherapy, and cardiovascular drugs. Read More
A closer look at the stakeholder requirements for the Drug Supply Chain Security Act as defined by Title II of the act. Requirements are broken down by each segment of the supply chain: manufacturers, re-packagers, wholesale distributors and dispensers. Read More